RO7790121, RO7790121 clinical trials

An Extension Study to Evaluate the Long-Term Safety and Efficacy of Afimkibart (RO7790121) in Patients with Rheumatoid Arthritis who Participated in Previous Afimkibart Clinical Trials

This study is an extension for people with moderate to severe rheumatoid arthritis who have already taken part in a trial for a drug called afimkibart. It looks at how safe and effective afimkibart is over a longer period, checking for side effects and how well it helps control their arthritis.